Medical Expert - Robert J. Applegate, PhD

Area of Expertise: Cardiology - Interventional/Stents
Media Contact: Paula Faria pfaria@wakehealth.edu
Media Office: 336-716-1279 Media Mobile: 336-528-3364
Patient Contact: Health On-Call® 1-800-446-2255

Robert J. Applegate, PhD

Professor, Cardiology

Dr. Applegate was the lead investigator of a study to evaluate the safety of drug-eluding stents with results published in the American Journal of Cardiology. The Heart Center at Wake Forest Baptist was one of the first in NC to participate in multicenter clinical trials. Applegate's team observed lower cumulative rates of non-fatal heart attacks and death at nine months in patients treated with drug-eluting stents compared to patients treated with bare metal stents. He is listed in Best Doctors in America.

Keywords

health services, research/outc, human, adult, cardiovascular system, medical technology/devices, drugs/therapeutic agents pharm, clinical trials

IN THE NEWS

Wake Forest Baptist Announces First Implant in Clinical Trial to Evaluate New Heart Valve Procedure
More than 100,000 patients who suffer from severe aortic stenosis, a condition that restricts blood flow from the heart to the body, are ineligible for open-heart valve replacement surgery. Today, Wake Forest Baptist Medical Center announced the enrollment of the first three patients in North Carolina to receive transcatheter aortic-valve implantation (TAVI) as part of the Medtronic CoreValve® U.S. Clinical Trial.
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.